Trial Profile
Effects of methylphenidate on cognition in patients with epilepsy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions; Therapeutic Use
- 10 May 2016 New trial record
- 21 Apr 2016 Results of double-blind portion of this study presented at the 68th Annual Meeting of the American Academy of Neurology